RENAL PHOSPHOLIPIDOSIS

RENAL PHOSPHOLIPIDOSIS was reported 136 times

RENAL PHOSPHOLIPIDOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Peroxisome Proliferator Receptor alpha Agonist [EPC] 20 0.0003
1 Echinocandin Antifungal [EPC] 2 0.0002
2 Glinide [EPC] 2 0.0002
3 Bismuth [EPC] 1 0.0002
4 Aldosterone Antagonist [EPC] 20 0.0001
5 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 12 0.0001
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0001
7 Purine Antimetabolite [EPC] 6 0.0001
8 Corticosteroid [EPC] 69 0.0001
9 Vitamin D [EPC] 15 0.0000
10 Thiazide Diuretic [EPC] 10 0.0000
11 Loop Diuretic [EPC] 22 0.0000
12 Antimetabolite Immunosuppressant [EPC] 1 0.0000
13 Vitamin B12 [EPC] 15 0.0000
14 General Anesthetic [EPC] 2 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 20 0.0000
16 Osmotic Laxative [EPC] 13 0.0000
17 Angiotensin 2 Receptor Blocker [EPC] 14 0.0000
18 Proton Pump Inhibitor [EPC] 22 0.0000
19 Vitamin C [EPC] 15 0.0000
20 Platelet Aggregation Inhibitor [EPC] 20 0.0000
21 Proteasome Inhibitor [EPC] 4 0.0000
22 alpha-Adrenergic Blocker [EPC] 4 0.0000
23 Azole Antifungal [EPC] 4 0.0000
24 Benzodiazepine [EPC] 17 0.0000
25 HMG-CoA Reductase Inhibitor [EPC] 9 0.0000
26 Nucleoside Analog Antiviral [EPC] 2 0.0000
27 Mood Stabilizer [EPC] 5 0.0000
28 Dihydropyridine Calcium Channel Blocker [EPC] 6 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 21 0.0000
30 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
31 beta-Adrenergic Blocker [EPC] 4 0.0000
32 Alkylating Drug [EPC] 3 0.0000
33 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
34 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
35 Factor Xa Inhibitor [EPC] 2 0.0000
36 Calcium [EPC] 1 0.0000